AM095 sodium salt 1345614-59-6 AM095 is a potent LPA1 receptor antagonist with IC50 values of 0.98 and 0.73 _mu_M for recombinant human or mouse LPA1 respectively.

Mertansine 139504-50-0 Mertansine refers to the thiol-containing maytansinoid, DM1 (N2’-deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) attached to a monoclonal antibody through reaction of the thiol

(R)-P7C3-Ome 1235481-43-2 P7C3 is a drug related to latrepirdine (dimebon), which has neuroprotective and proneurogenic effects

PFI-2 1627676-59-8 PFI-2 is a potent, selective, and cell-active lysine methyltransferase SETD7 inhibitor with Ki (app) and IC50 of 0.33 nM and 2 nM,

Atopaxar Hydrobromide 474550-69-1 Atopaxar Hydrobromide is a reversible protease activated receptor (PAR)-1 thrombin receptor antagonist that interferes with platelet signaling.

Atopaxar 751475-53-3 Atopaxar is a reversible protease activated receptor (PAR)-1 thrombin receptor antagonist that interferes with platelet signaling.

Cinaciguat 329773-35-5 Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in clinical development for acute decompensated heart failure.

HA14-1 65673-63-4 HA14-1 is a non-peptidic ligand of a Bcl-2 surface pocket with IC50 of ~9 μM.